Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Research Associate, Chromatography/Biophysical Characterization

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
May 12, 2022

View more

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How You Will Achieve More With Intellia:

Be the next Research Associate to join our Analytical Development team! In this role, you will be responsible for executing analytical procedures relevant to gene therapy and cell therapy platforms. This will include handling advanced nucleic acid-based analytical chromatography including RP-HPLC, IEX, Electrophoresis-based methods (Fragment analyzer, CE), and Mass spectrometry-based methods.

  • Execute analytical test methods to support routine process development and stability samples

  • Compliant with GxP, keep good lab notebook and experiment records

  • Routinely perform and participate in the optimization and execution of analytical methods required to support CMC

  • Support tech transfer of analytical methods, protocols/procedures, and know-how from internal labs to external labs

  • Work collaboratively with Process Development to gather and analyze data to develop an understanding of product critical quality attributes to guide testing and process control strategies.

  • Work closely with and support quality control on investigations, OOS, OOTs and release assay trouble-shooting

  • Support project leads, key internal and external stakeholders to meet project deadlines

About You:

  • BS with 2 years of experience in nucleic acid molecular biology or related fields in the pharmaceutical or biotechnology industry

  • Experience working on cell and gene therapy products highly desirable

  • Demonstrated ability in problem solving and organization

  • Excellent written and oral communication skills

  • Team player, good interpersonal and organizational skills

  • Knowledge of QC and GMP regulations is desirable

#LI-LN1

Covid-19 Vaccination Policy: Effective Monday, January 3, 2022, all Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert